These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7352851)

  • 1. Effect of antiparkinsonian medication on plasma levels of chlorpromazine.
    Simpson GM; Cooper TB; Bark N; Sud I; Lee JH
    Arch Gen Psychiatry; 1980 Feb; 37(2):205-8. PubMed ID: 7352851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.
    Manos N; Gkiouzepas J; Logothetis J
    Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
    Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
    Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):115-21. PubMed ID: 1103206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled trial of trihexyphenidyl in unmedicated patients with schizophrenia.
    Goff DC; Amico E; Dreyfuss D; Ciraulo D
    Am J Psychiatry; 1994 Mar; 151(3):429-31. PubMed ID: 8109654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
    Rivera-Calimlim L; Nasrallah H; Strauss J; Lasagna L
    Am J Psychiatry; 1976 Jun; 133(6):646-52. PubMed ID: 5901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuing antiparkinson medication in chronic schizophrenics. At what cost to the patient?
    Manos N; Gkiouzepas J
    Acta Psychiatr Scand; 1981 Jan; 63(1):28-32. PubMed ID: 6112842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the antiparkinsonian drugs on the plasma level of neuroleptics.
    Gautier J; Jus A; Villeneuve A; Jus K; Pires P; Villeneuve R
    Biol Psychiatry; 1977 Jun; 12(3):389-99. PubMed ID: 871490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
    Peet M; Middlemiss DN; Yates RA
    Br J Psychiatry; 1981 Aug; 139():112-7. PubMed ID: 7030443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
    Cooper SF; Albert JM; Hillel J; Caille G
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics.
    Rinieris P; Hatzimanolis J; Markianos M; Stefanis C
    Eur Arch Psychiatry Neurol Sci; 1988; 237(4):189-93. PubMed ID: 3203697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping.
    Singh MM; Kay SR; Opler LA
    Psychol Med; 1987 Feb; 17(1):39-48. PubMed ID: 3575576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clotiapine compared with chlorpromazine in chronic schizophrenia.
    Geller V; Gorzaltsan I; Shleifer T; Belmaker RH; Bersudsky Y
    Schizophr Res; 2005 Dec; 80(2-3):343-7. PubMed ID: 16126373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocarditis after overdose of conventional antipsychotics.
    Bhatia MS; Gupta R; Dhawan J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):606-8. PubMed ID: 17965989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
    Hershey LA; Gift T; Atkins RW; Rivera-Calimlim L
    Psychopharmacology (Berl); 1981; 73(4):355-8. PubMed ID: 6789357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiparkinsonian medication in depressed schizophrenics on depot neuroleptics.
    Bennie EH
    Br J Psychiatry; 1982 Feb; 140():210. PubMed ID: 6122482
    [No Abstract]   [Full Text] [Related]  

  • 19. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo.
    Peet M; Bethell MS; Coates A; Khamnee AK; Hall P; Cooper SJ; King DJ; Yates RA
    Br J Psychiatry; 1981 Aug; 139():105-11. PubMed ID: 7030442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.